U.S. Food and Drug Administration Issues Non-Approvable Letter for … at Regulatory Affairs Syndicator

U.S. Food and Drug Administration Issues Non-Approvable Letter for …

Published by MSN Search News: "Food and Drug Administration" October 23rd, 2006 in Regulatory Affairs

Syracuse Post-Standard - LOUISVILLE, Colo. and NEW YORK, Oct. 23 /PRNewswire-FirstCall/ — Replidyne, Inc. (Nasdaq: RDYN ) and Forest Laboratories, Inc. (NYSE: FRX ), reported today the U.S. Food and Drug Administration (FDA) has issued a non- approvable letter for Replidyne …